Cancer Rop Co., Ltd. develops and commercializes molecular diagnostic techniques for various genetic diseases in South Korea. The company offers BAC chip, a gene based microarray to detect chromosomal abnormalities in embryos for increasing success rate of in vitro fertilization, check health of fetus, diagnose chromosomal abnormalities in children and adults with health problems, detect chromosomal abnormalities in cancer cells, and check chromosomal abnormalities in stem cells. It is also developing reagents for diagnostic tools that are used in the diagnosis of cervical cancer, sexually transmitted infections, and other diseases. The company was formerly known as MG MED, Inc. and changed its name to Cancer Rop Co., Ltd. in January 2018. Cancer Rop Co., Ltd. was founded in 2001 and is based in Seoul, South Korea.